A meta-analysis of 55 studies across 10 countries describing outcomes with peer review of radiotherapy plans reports a whooping 28% of all reviewed cases are recommended to undergo revisions, nearly half of which were considered major. Precisely half of revisions were related to contouring of target (45%) or critical structures (5%). Most of the remaining changes were related to the dose received by target (33%) or critical structures (9%). While an accompanying editorial leans on this data to call for formal peer review in future accreditation metrics, there is much left to be desired from this surface level data. Notably, when followed, these recommended revisions were actually implemented little more than half the time, likely influenced both by the complexity and timing of the proposed change. Most importantly, it is unclear to what degree, if any, suggested revisions would measurably improve clinical outcomes beyond shifting plans towards arbitrary institutional standards. | Jomy, Radiother Oncol 2024

